The forkhead DNA-binding domain binds specific G2-rich RNA sequences.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
11 Dec 2023
Historique:
accepted: 17 10 2023
revised: 06 09 2023
received: 31 03 2023
pubmed: 7 11 2023
medline: 7 11 2023
entrez: 7 11 2023
Statut: ppublish

Résumé

Transcription factors contain a DNA-binding domain ensuring specific recognition of DNA target sequences. The family of forkhead (FOX) transcription factors is composed of dozens of paralogs in mammals. The forkhead domain (FHD) is a segment of about 100 amino acids that binds an A-rich DNA sequence. Using DNA and RNA PCR-SELEX, we show that recombinant FOXL2 proteins, either wild-type or carrying the oncogenic variant C134W, recognize similar DNA-binding sites. This suggests that the oncogenic variant does not alter the intrinsic sequence-specificity of FOXL2. Most importantly, we show that FOXL2 binds G2-rich RNA sequences whereas it virtually fails to bind similar sequences in DNA chemistry. Interestingly, a statistically significant subset of genes responding to the knock-down of FOXL2/Foxl2 harbor such G2-rich sequences and are involved in crucial signaling pathways and cellular processes. In addition, we show that FOXA1, FOXO3a and chimeric FOXL2 proteins containing the FHD of the former are also able to interact with some of the preferred FOXL2-binding sequences. Our results point to an unexpected and novel characteristic of the forkhead domain, the biological relevance of which remains to be explored.

Identifiants

pubmed: 37933840
pii: 7337609
doi: 10.1093/nar/gkad994
pmc: PMC10711433
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12367-12380

Subventions

Organisme : University of Paris Cité
Organisme : Centre National de la Recherche Scientifique
Organisme : Agence National pour la La Recherche
Organisme : Agence Nationale pour la Recherche' Investissement d'Avenir
ID : ANR-11-INBS-0011

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Am J Hum Genet. 1983 Sep;35(5):1020-7
pubmed: 6613996
FASEB J. 2021 Apr;35(4):e21355
pubmed: 33749886
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Cell. 2012 Jan 20;148(1-2):99-111
pubmed: 22265405
Science. 2016 Sep 23;353(6306):
pubmed: 27708011
J Med Genet. 2002 Dec;39(12):916-21
pubmed: 12471206
Dev Biol. 2002 Oct 1;250(1):1-23
pubmed: 12297093
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W676-82
pubmed: 16845096
Biochem J. 2004 Jun 1;380(Pt 2):297-309
pubmed: 15005655
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W202-8
pubmed: 19458158
Nat Commun. 2020 Apr 24;11(1):2010
pubmed: 32332759
Elife. 2014 Nov 04;3:
pubmed: 25369636
PLoS One. 2010 Jan 20;5(1):e8789
pubmed: 20098707
Biochimie. 2012 Apr;94(4):1057-68
pubmed: 22234303
Cancer Res. 2020 Sep 1;80(17):3466-3479
pubmed: 32641411
Nature. 1992 Feb 6;355(6360):564-6
pubmed: 1741036
Hum Mol Genet. 2008 Jul 1;17(13):2030-8
pubmed: 18372316
Nucleic Acids Res. 2008 Jan;36(Database issue):D381-5
pubmed: 17962308
J Med Genet. 2004 Dec;41(12):932-6
pubmed: 15591279
Trends Genet. 2014 Jun;30(6):211-9
pubmed: 24774859
Nat Methods. 2007 Mar;4(3):251-6
pubmed: 17293868
Nucleic Acids Res. 2005 May 24;33(9):2908-16
pubmed: 15914667
J Mol Endocrinol. 2004 Dec;33(3):705-15
pubmed: 15591029
Science. 2009 Jun 26;324(5935):1720-3
pubmed: 19443739
FASEB J. 2020 Jan;34(1):571-587
pubmed: 31914586
Biochem Biophys Res Commun. 2020 May 21;526(1):261-266
pubmed: 32209257
Trends Genet. 2021 May;37(5):460-475
pubmed: 33303287
N Engl J Med. 2009 Jun 25;360(26):2719-29
pubmed: 19516027
Genome Biol. 2021 Apr 23;22(1):117
pubmed: 33892767
Genome Biol. 2020 Sep 1;21(1):226
pubmed: 32873317
Nat Genet. 2001 Feb;27(2):159-66
pubmed: 11175783
Hum Mol Genet. 2011 Sep 1;20(17):3376-85
pubmed: 21632871
Cancer Res. 2020 Sep 1;80(17):3480-3491
pubmed: 32641414
Hum Mol Genet. 2012 Jul 15;21(14):3264-74
pubmed: 22544055
Methods Mol Biol. 2017;1575:253-272
pubmed: 28255886
Pharmaceuticals (Basel). 2016 Dec 10;9(4):
pubmed: 27973417
Appl Environ Microbiol. 2012 Aug;78(15):5440-3
pubmed: 22610439

Auteurs

Caroline Zutterling (C)

Université Paris Cité, CNRS, Institut Jacques Monod, CNRS UMR7592, Paris 75013, France.

Anne-Laure Todeschini (AL)

Université Paris Cité, CNRS, Institut Jacques Monod, CNRS UMR7592, Paris 75013, France.

Deborah Fourmy (D)

Molecular Imaging Research Center, Fontenay-aux-Roses, France.
Université Paris Saclay, France.
Institut de Biologie François Jacob, CEA, Fontenay aux Roses, France.

Didier Busso (D)

Université Paris Saclay, France.
Institut de Biologie François Jacob, CEA, Fontenay aux Roses, France.
CIGEx platform. UMR Stabilité Génétique Cellules Souches et Radiations, Fontenay-aux-Roses, France.

Xavier Veaute (X)

Université Paris Saclay, France.
Institut de Biologie François Jacob, CEA, Fontenay aux Roses, France.
CIGEx platform. UMR Stabilité Génétique Cellules Souches et Radiations, Fontenay-aux-Roses, France.

Frédéric Ducongé (F)

Molecular Imaging Research Center, Fontenay-aux-Roses, France.
Université Paris Saclay, France.
Institut de Biologie François Jacob, CEA, Fontenay aux Roses, France.

Reiner A Veitia (RA)

Université Paris Cité, CNRS, Institut Jacques Monod, CNRS UMR7592, Paris 75013, France.
Université Paris Saclay, France.
Institut de Biologie François Jacob, CEA, Fontenay aux Roses, France.

Classifications MeSH